V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20212274 | 20128707 | 1.75 | 76 | Palliative (P) | 2018-07-05 | 2018-12-07 | ECX | null | N | ECX | 100103463 |
| 20212279 | 20128708 | null | 46.9 | null | 2017-04-29 | 2017-12-16 | Carboplatin + Etoposide iv&po | null | null | CARBOPLATIN + ETOPOSIDE | 101160782 |
| 20212281 | 20128709 | 1.75 | 55.9 | Neo-adjuvant (N) | 2018-09-25 | 2018-10-08 | Carboplatin + Etoposide iv&po | N | N | CARBOPLATIN + ETOPOSIDE | 100292518 |
| 20212282 | 20128710 | 1.62 | 72.85 | Neo-adjuvant (N) | 2018-10-07 | 2018-10-10 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101382333 |
| 20212286 | 20128711 | 1.81 | 75.7 | Curative (C) | 2021-07-22 | 2021-07-22 | Carboplatin + Etoposide iv&po | null | null | PANITUMUMAB | 101582742 |
| 20212289 | 20128712 | 1.6 | 79.5 | Neo-adjuvant (N) | 2016-08-17 | 2016-08-18 | null | 2 | N | CARBOPLATIN + ETOPOSIDE | 100277136 |
| 20212291 | 20128713 | 1.7 | 88 | Neo-adjuvant (N) | 2019-10-25 | 2019-10-31 | null | null | N | CARBOPLATIN + ETOPOSIDE | 101774599 |
| 20212294 | 20128714 | 1.7 | 150.7 | Neo-adjuvant (N) | 2017-08-01 | 2017-08-23 | Carboplatin + Etoposide IV 3 day | N | N | CARBOPLATIN + ETOPOSIDE | 100988487 |
| 20212297 | 20128715 | 1.69 | 80 | 03 | 2020-12-21 | 2020-12-31 | CARBOPLATIN + ETOPOSIDE | 02 | null | CARBOPLATIN + ETOPOSIDE | 101539727 |
| 20212300 | 20128716 | 1.72 | 88 | null | 2017-05-09 | 2017-05-23 | null | 02 | N | PANITUMUMAB | 101385454 |
| 20212301 | 20128717 | null | 86.85 | Palliative (P) | 2020-07-19 | 2020-07-21 | null | N | null | ECX | 100289645 |
| 20212302 | 20128718 | 1.72 | 94 | Palliative (P) | 2019-05-22 | 2019-08-14 | null | 02 | N | CISPLATIN + FLUOROURACIL | 100519828 |
| 20212303 | 20128719 | null | null | Palliative (P) | 2020-04-21 | 2020-04-21 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100931059 |
| 20212305 | 20128720 | 1.73 | null | Adjuvant (A) | 2018-01-01 | 2018-01-04 | CISPLATIN + FLUOROURACIL | N | N | CISPLATIN + FLUOROURACIL | 101272450 |
| 20212307 | 20128721 | 1.7 | null | Curative (C) | 2019-09-29 | 2019-09-29 | null | 02 | N | CARBOPLATIN + ETOPOSIDE | 101851032 |
| 20212310 | 20128724 | 1.64 | 63 | Adjuvant (A) | 2019-10-03 | 2019-10-27 | null | N | null | NIVOLUMAB | 101273272 |
| 20212312 | 20128726 | 1.83 | null | Neo-adjuvant (N) | 2018-06-13 | 2018-06-15 | ECX | 02 | N | ECX | 100265933 |
| 20212313 | 20128727 | 1.58 | 77.6 | Neo-adjuvant (N) | 2018-02-13 | 2018-04-22 | null | N | N | PANITUMUMAB | 100712058 |
| 20212314 | 20128728 | 1.75 | 106 | Palliative (P) | 2019-04-13 | 2019-11-29 | CARBOPLATIN + ETOPOSIDE | null | N | CARBOPLATIN + ETOPOSIDE | 100885786 |
| 20212316 | 20128729 | 1.79 | 83.8 | Adjuvant (A) | 2017-12-25 | 2018-01-03 | null | 2 | N | CISPLATIN + FLUOROURACIL | 101717371 |
| 20212320 | 20128730 | 1.7 | 68.6 | Neo-adjuvant (N) | 2018-07-24 | 2018-08-07 | null | 2 | N | CARBOPLATIN + ETOPOSIDE | 100941299 |
| 20212321 | 20128731 | 1.69 | 65.2 | Palliative (P) | 2017-03-27 | 2018-06-11 | null | N | N | ECX | 100321559 |
| 20212322 | 20128732 | 1.82 | 97.7 | Palliative (P) | 2020-08-10 | 2020-08-11 | NIVOLUMAB | null | N | NIVOLUMAB | 100279759 |
| 20212325 | 20128733 | 1.75 | 70.3 | Curative (C) | 2017-09-09 | 2017-09-09 | NIVOLUMAB | null | N | NIVOLUMAB | 101032392 |
| 20212326 | 20128734 | null | 80.15 | Neo-adjuvant (N) | 2016-08-24 | 2016-09-04 | ECX | 02 | N | ECX | 100187315 |
| 20212328 | 20128735 | 1.86 | null | Adjuvant (A) | 2016-03-06 | 2016-03-07 | null | N | N | ECX | 101321861 |
| 20212331 | 20128737 | null | 72.3 | Palliative (P) | null | 2017-08-18 | ECX | 2 | null | ECX | 100928526 |
| 20212334 | 20128738 | null | 101 | null | 2018-03-15 | 2018-03-19 | CARBOPLATIN + ETOPOSIDE | 2 | Y | CARBOPLATIN + ETOPOSIDE | 101484850 |
| 20212335 | 20128739 | 1.75 | null | Neo-adjuvant (N) | 2017-04-25 | 2017-05-01 | null | N | N | PANITUMUMAB | 100702631 |
| 20212340 | 20128741 | 1.78 | 52 | Palliative (P) | 2018-06-23 | 2018-07-04 | NIVOLUMAB | null | N | NIVOLUMAB | 100176778 |
| 20212343 | 20128744 | 1.7 | 65.2 | 03 | 2018-06-25 | 2018-07-05 | NIVOLUMAB | 2 | null | NIVOLUMAB | 100625968 |
| 20212345 | 20128745 | 1.81 | 74.2 | Neo-adjuvant (N) | 2020-03-21 | 2020-03-25 | NIVOLUMAB | null | N | NIVOLUMAB | 101743027 |
| 20212346 | 20128746 | 1.75 | null | Neo-adjuvant (N) | 2018-07-10 | 2018-07-13 | CARBOPLATIN + ETOPOSIDE | 02 | N | CARBOPLATIN + ETOPOSIDE | 100596623 |
| 20212347 | 20128747 | null | 98.7 | Palliative (P) | 2016-02-19 | 2016-03-16 | null | N | null | CARBOPLATIN + ETOPOSIDE | 100714254 |
| 20212353 | 20128749 | 1.7 | null | Palliative (P) | 2018-04-15 | 2018-11-24 | NIVOLUMAB | 2 | null | NIVOLUMAB | 101005403 |
| 20212362 | 20128752 | 1.72 | 46.6 | Adjuvant (A) | 2019-02-06 | 2019-04-20 | ECX | N | N | ECX | 101030401 |
| 20212366 | 20128754 | 1.57 | null | null | 2016-08-05 | 2016-08-10 | Carboplatin + Etoposide IV 3 day | 2 | null | CARBOPLATIN + ETOPOSIDE | 101472047 |
| 20212369 | 20128755 | 1.72 | 73.8 | Palliative (P) | 2018-11-15 | 2018-12-19 | Panitumumab | N | N | PANITUMUMAB | 100787232 |
| 20212371 | 20128756 | 1.63 | 79 | Adjuvant (A) | 2017-08-01 | 2017-08-05 | CISPLATIN + FLUOROURACIL | N | N | CISPLATIN + FLUOROURACIL | 100310925 |
| 20212374 | 20128757 | 1.77 | 59.6 | 03 | 2016-11-06 | 2016-11-21 | Panitumumab | N | N | PANITUMUMAB | 100733027 |
| 20212375 | 20128758 | 1.66 | 55.5 | null | 2017-02-27 | 2017-07-19 | Carboplatin + Etoposide iv&po | null | Y | CARBOPLATIN + ETOPOSIDE | 101594519 |
| 20212376 | 20128759 | 1.69 | 54.9 | null | 2020-03-04 | 2020-03-11 | Panitumumab | null | N | PANITUMUMAB | 100930999 |
| 20212380 | 20128761 | 1.79 | 74.6 | Neo-adjuvant (N) | 2020-03-05 | 2020-03-25 | null | 02 | N | CISPLATIN + FLUOROURACIL | 101689472 |
| 20212381 | 20128762 | 1.69 | null | Neo-adjuvant (N) | 2018-01-28 | 2018-02-10 | null | N | N | CARBOPLATIN + ETOPOSIDE | 101719806 |
| 20212385 | 20128763 | 0 | 48.35 | null | null | 2016-11-02 | Panitumumab | 02 | N | PANITUMUMAB | 100623997 |
| 20212386 | 20128764 | 1.67 | 83.8 | Adjuvant (A) | 2018-07-22 | 2018-09-03 | Panitumumab | 02 | N | PANITUMUMAB | 101207401 |
| 20212390 | 20128765 | 1.85 | 88.5 | null | 2017-12-14 | 2018-01-06 | CARBOPLATIN + ETOPOSIDE | N | Y | CARBOPLATIN + ETOPOSIDE | 100249390 |
| 20212391 | 20128766 | null | null | Palliative (P) | 2018-05-16 | 2018-05-31 | null | N | N | CISPLATIN + FLUOROURACIL | 100476142 |
| 20212392 | 20128767 | 1.75 | 85.8 | Palliative (P) | 2020-04-21 | 2020-04-25 | Carboplatin + Etoposide iv&po | N | N | CARBOPLATIN + ETOPOSIDE | 101465923 |
| 20212393 | 20128768 | 1.82 | 43.4 | Neo-adjuvant (N) | 2018-07-20 | 2018-07-21 | null | 2 | N | PANITUMUMAB | 100060888 |